Literature DB >> 30344904

Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents.

Charlotte Courtens1, Martijn Risseeuw1, Guy Caljon2, Paul Cos2, Serge Van Calenbergh1.   

Abstract

Two classes of prodrugs of a fosmidomycin surrogate were synthesized and investigated for their ability to inhibit in vitro growth of P. falciparum and M. tuberculosis. To this end, a novel efficient synthesis route was developed involving a cross metathesis reaction as a key step. Alkoxyalkyl prodrugs show decent antimalarial activities, but acyloxybenzyl prodrugs proved to be the most interesting and show enhanced antimalarial and antitubercular activity. The most active antimalarial analogues show low nanomolar IC50 values.

Entities:  

Year:  2018        PMID: 30344904      PMCID: PMC6187408          DOI: 10.1021/acsmedchemlett.8b00223

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

1.  Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.

Authors:  Sarah Ponaire; Catherine Zinglé; Denis Tritsch; Catherine Grosdemange-Billiard; Michel Rohmer
Journal:  Eur J Med Chem       Date:  2012-02-25       Impact factor: 6.514

2.  Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.

Authors:  Jochen Wiesner; Regina Ortmann; Hassan Jomaa; Martin Schlitzer
Journal:  Arch Pharm (Weinheim)       Date:  2007-12       Impact factor: 3.751

3.  Synthesis and evaluation of alpha-halogenated analogues of 3-(acetylhydroxyamino)propylphosphonic acid (FR900098) as antimalarials.

Authors:  Thomas Verbrugghen; Paul Cos; Louis Maes; Serge Van Calenbergh
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

4.  The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.

Authors:  Aengus Mac Sweeney; Roland Lange; Roberta P M Fernandes; Henk Schulz; Glenn E Dale; Alice Douangamath; Philip J Proteau; Christian Oefner
Journal:  J Mol Biol       Date:  2005-01-07       Impact factor: 5.469

5.  Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.

Authors:  Eugene Uh; Emily R Jackson; Géraldine San Jose; Marcus Maddox; Robin E Lee; Richard E Lee; Helena I Boshoff; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2011-10-05       Impact factor: 2.823

6.  Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.

Authors:  Steffen Borrmann; Ayola A Adegnika; Pierre-Blaise Matsiegui; Saadou Issifou; Andreas Schindler; Denise P Mawili-Mboumba; Thomas Baranek; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  J Infect Dis       Date:  2004-02-16       Impact factor: 5.226

Review 7.  Mechanism and inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.

Authors:  Andrew S Murkin; Kathryn A Manning; Svetlana A Kholodar
Journal:  Bioorg Chem       Date:  2014-06-19       Impact factor: 5.275

8.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

Review 9.  Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents.

Authors:  Tiziana Masini; Anna K H Hirsch
Journal:  J Med Chem       Date:  2014-09-25       Impact factor: 7.446

10.  Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake.

Authors:  Amanda C Brown; Tanya Parish
Journal:  BMC Microbiol       Date:  2008-05-20       Impact factor: 3.605

View more
  2 in total

1.  Toward a structome of Acinetobacter baumannii drug targets.

Authors:  Logan M Tillery; Kayleigh F Barrett; David M Dranow; Justin Craig; Roger Shek; Ian Chun; Lynn K Barrett; Isabelle Q Phan; Sandhya Subramanian; Jan Abendroth; Donald D Lorimer; Thomas E Edwards; Wesley C Van Voorhis
Journal:  Protein Sci       Date:  2020-01-20       Impact factor: 6.725

2.  Synthesis of 4-thiouridines with prodrug functionalization for RNA metabolic labeling.

Authors:  Sarah Moreno; Melanie Brunner; Isabel Delazer; Dietmar Rieder; Alexandra Lusser; Ronald Micura
Journal:  RSC Chem Biol       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.